Method for constructing murine model with mutations in csflr gene and application thereof
A mutated Csf1r gene is disclosed. The mutated Csf1r gene is obtained by changing the 2557th nucleotide of a Csf1r gene from C to A, leading to obtain a mutated protein encoded by the mutated Csf1r gene substitute the 853rd amino acid from proline to threonine. The mutated protein, expression vectors, recombinant viruses, recombinant cells, recombinant bacteria, or recombinant vectors are also disclosed. A method for constructing a murine model with mutations in Csf1r gene. This method includes introducing the targeted vector containing the mutated Csf1r gene into mouse embryonic stem cells, followed by injection into blastocysts to generate F0 generation mice. The F0 generation mice are then bred with mice that specifically express Cre enzyme in tissues, followed by screening. The constructed murine model has significant applications in studying the pathogenic mechanisms of brain diseases caused by microglial cell dysfunction and screening valuable medicine for treating brain diseases.
1 . A mutated Csf1r (Colony stimulating factor 1 receptor) gene, wherein the mutated Csf1r gene is obtained by changing 2557th nucleotide of a Csf1r gene from C to A; the mutated Csf1r gene is shown in SEQ ID NO: 1.
2 . A mutated Csf1r protein, wherein the mutated Csf1r protein is encoded by the mutated Csf1r gene of claim 1 ; the mutated Csf1r protein is obtained by substituting proline with threonine at the 853rd amino acid position of a Csf1r protein; the amino acid sequence of the mutated Csf1r protein is shown in SEQ ID NO: 2.
3 . An expression cassette, recombinant virus, recombinant cell, recombinant bacteria, or recombinant vector, comprising the mutated Csf1r gene of claim 1 .
4 . A method for constructing a murine model with mutations in Csf1r gene, comprising the following steps:
(1) constructing a targeting vector, Csf1r P853T/+ , containing the mutated Csf1r gene of claim 1 ;
(2) electroporating the targeting vector Csf1r P853T/+ obtained in step (1) into mouse embryonic stem cells and verifying positive clones;
(3) injecting the verified positive mouse embryonic stem cells from step (2) into blastocysts and transplanting the blastocysts into the uteri of female mice to obtain F0 generation mice;
(4) breeding the F0 generation mice obtained in step (3) with mice that express Cre enzyme in a tissue-specific manner and selecting F1 generation heterozygous mice that carry both the point mutation in step (1) and the Cre gene in their genomes;
(5) pairing two heterozygous F1 generation mice obtained in step (4) and selecting F2 generation homozygous mice, thereby obtaining the desired murine model.
5 . The method according to claim 4 , wherein the mice that express Cre enzyme specifically in tissues are mice that express Cre enzyme in macrophages.
6 . The method according to claim 4 , wherein the F2 generation homozygous mice are mice afflicted with brain diseases caused by microglial dysfunction.